Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT), as one of the life-saving treatments for severe aplastic anemia (SAA), is widely used because of its great donor availability. Over decades, granulocyte colony-stimulating factor (G-CSF)/antithymocyte globulin (ATG)-based protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaodi, Xu, Zhengli, Han, Tingting, Zhang, Yuanyuan, Han, Wei, Fu, Haixia, Zhang, Xiaohui, Lin, Fan, Huang, Xiaojun, Xu, Lanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206175/
https://www.ncbi.nlm.nih.gov/pubmed/37234156
http://dx.doi.org/10.3389/fimmu.2023.1173320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206175/
https://www.ncbi.nlm.nih.gov/pubmed/37234156
http://dx.doi.org/10.3389/fimmu.2023.1173320

Ejemplares similares